Anzeige
Erschienen in:
06.12.2019 | Atrial Fibrillation
Immediate and long-term outcomes of cryoballoon catheter ablation in patients with atrial fibrillation and left common pulmonary vein anatomy
Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 1/2020
Einloggen, um Zugang zu erhaltenAbstract
Purpose
The efficacy of cryoballoon (CB) for atrial fibrillation (AF) ablation is still debatable in case of anatomical variations like left common pulmonary vein (LCPV). We aimed to assess the impact of LCPV trunk on the acute and long-term clinical outcomes in patients with CB based AF ablation.
Methods
We compared a total of 82 AF patients (62.5% paroxysmal and 37.5% persistent) who underwent pulmonary vein isolation using CB (LCPV+ group) with a propensity score–matched cohort of 76 AF patients (LCPV− group) (61.8% paroxysmal and 38.2% persistent). Preprocedural computed tomography was performed in all patients and ostial dimensions and trunk distance were measured. Atrial tachyarrhythmia (ATa) recurrence was defined as detection of AF, atrial flutter, or atrial tachycardia (≥ 30 s) after a 3-month blanking period.
Results
Acute procedural success was similar between the groups (100% and 98.7% for LCPV− and LCPV+, respectively, P = 0.991). Overall, 22/76 (28.9%) patients in LCPV− and 21/82 (25.6%) patients in LCPV+ had ATa recurrence at a mean follow-up of 31 ± 15 months (P = 0.770). A multivariate analysis identified only the left atrial (LA) diameter as a predictor of recurrent ATs (HR, 3.28; 95% CI, 1.67–6.41; P = 0.001). In the LCPV+ group, patients with single application had higher ATa recurrence (8/18 patients) compared with sequential freeze group (13/64 patients) (P = 0.042).
Conclusions
Our findings indicated that CB was an effective tool in patients with LCPV and freedom from ATa was similar between LCPV− and LCPV+ groups. Only LA diameter predicted the ATa recurrence during long-term follow-up.